Boundary Capital
Impact investorNorthampton · Pre-Seed–Growth · 2 people tracked
Find your way into Boundary Capital
517 people in our graph share verified history with the Boundary Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Boundary Capital backs high-growth private technology companies that it believes can positively impact millions of lives. The firm's team brings blue-chip commercial and academic experience across life sciences, artificial intelligence, and engineering, drawing on a track record of founding, investing in, and exiting multiple businesses. This combined operator and investor background informs a focus on technology-driven ventures with significant potential for scale and societal impact.
Source: firm website, verified Aug 23, 2026.
Team · 2 people
from the firm's website & public directories
What they invest in
from 4 of 27 portfolio companiesAI & Machine Learning ×2Deep Tech ×2Biotech ×1Digital Health ×1EdTech ×1Fintech ×1Healthtech ×1Medical Devices ×1
HQs:United Kingdom×2
Investments · 27 tracked
founders shown can be your intro pathBodyswaps provides immersive learning experiences, likely VR or virtual simulations, for educational institutions including further education colleges and apprenticeship providers.
AI & Machine LearningEdTechSaaSLondon, GB
Christophe Mallet(Chief Executive Officer)inTom Szirtes(Chief Product & Technology Officer)inJulien Denoel(Chief Operations Officer)in
Co-investorsHaatchUfi VocTech Trust
Glyconics develops medical diagnostic devices using spectroscopy (light-with-matter technology) to support low-cost medical diagnosis and disease management for patients and healthcare practice.
Deep TechDigital HealthHealthtechMedical Devices
Andrew Round(Chief Executive Officer (ad interim))Dr. Päivi Maria Paldánius(Chief Medical Officer & Chief Operating Officer)Sebastien Cuvelier Mussalian(Chief Technology Officer)Dr. Phil Taday(Head of R&D)Paul Jesson(Chief Finance Officer)
Co-investorsAnglia Capital GroupDeepbridge Capital
This page is a podcast interview/article about Empirical Ventures, not a company website.
AI & Machine LearningDeep TechFintechLondon, GB
Johnathan Matlock(Co-founder and General Partner)
Advanced wound care therapy delivering continuous topical oxygen to accelerate healing.
Co-investorsAmadeus Capital Partners
Supplies machines and supplies that kill weeds without using herbicides.
Co-investorsCalculus Capital Ltd.
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BC ABBC Dymag MAIN HIGH RESBC EchionBC glyconicsBitcoin Farming AdvisoryBusinessBusiness MatchingBusiness StrategyCelixirFinancialImage ScanInductosenseInvestingInvestmentMarket ResearchMeetingMergerMerger AcquisitionPlanningResearchStockTorsion
Portfolio news
latest coverage across their companiesPrincipals & officers · per Companies House
what is this? ⓘDirector · British · since 2009
Daniel Peter Somers — 75–100% of shares, 75–100% of voting rights, right to appoint and remove directors, significant influence or control
Frequently asked questions
- How many investments has Boundary Capital made?
- Boundary Capital has 47 tracked investments.
- What stage does Boundary Capital invest at?
- Boundary Capital invests at the Pre-Seed, Seed, Series A, Growth stages.
- What is Boundary Capital's typical check size?
- Boundary Capital typically writes checks of $190.5K – $635K.
- What sectors does Boundary Capital focus on?
- Boundary Capital focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Data & Infrastructure, Deep Tech, Healthtech, Impact & Social Good.
- Where is Boundary Capital located?
- Boundary Capital is headquartered in Northampton, GB.
- Who does Boundary Capital co-invest with?
- Boundary Capital most often shares deals with Calculus Capital Ltd., Haatch, Ufi VocTech Trust, among 3 tracked co-investors.
Media · Podcasts & interviews
featuring the teamGrowthInvest Adviser Hour: Interview with Dan Somers of Boundary Capital
Boundary Capital · Dan
Images
Co-investors · 1
Sana Capital invests in growth-stage healthcare businesses at the intersection of services and technology, focusing on sustainable solutions that improve access, outcomes, and costs while promoting health equity in underserved communities.
Firms observed investing alongside Boundary Capital, from public investor directories. Shared companies are the overlap with Boundary Capital's recorded portfolio.
Similar investors
Neulogy Ventures is a venture capital firm backing early-stage technology companies, with a focus on ambitious ideas across technology, climate and health, primarily in the Central and Eastern Europe region.
Starquest Capital is an impact-focused investment firm dedicated to financing disruptive green technologies that reduce emissions, protect biodiversity, and enable climate adaptation. It operates several thematic funds: a Biodiversity Fund, a CCR-Fund for climate adaptation and disaster prevention, and a Protect fund for decarbonization technologies.
Innovobot is an investment and innovation platform focused on deep tech, combining a venture fund (IRV), an innovation studio (Innovobot Labs), and engineering services to foster technologies that address social, industrial and environmental challenges.
MDI Ventures is the corporate venture capital arm of Telkom Indonesia, investing in and building synergies between technology startups and Indonesian enterprises. It manages a multi-fund platform (including Centauri Fund, Arise, and sector-specific funds) with a portfolio of 80+ companies.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.